2023
Chronic opioid use and mortality outcomes in patients admitted with COVID-19: A retrospective cohort study.
Patel A, Kim J, Brown D, Lin H, Ouyang Y, Shekane P. Chronic opioid use and mortality outcomes in patients admitted with COVID-19: A retrospective cohort study. Journal Of Opioid Management 2023, 19: 321-327. PMID: 37644790, DOI: 10.5055/jom.2023.0789.Peer-Reviewed Original ResearchConceptsHigh-flow nasal cannulaOpioid use groupChronic opioid usePropensity Score Matching AnalysisLength of stayMechanical ventilationScore matching analysisOpioid useBilevel positive airway pressureRetrospective review of electronic medical recordsOpioid naive patientsChronic opioid usersPositive airway pressureReview of electronic medical recordsOxygen requirementUse groupFlow nasal cannulaImpact of opioidsMatching AnalysisRetrospective cohort studyPatients admitted with COVID-19In-Hospital MortalityCOVID-19 patientsNaive patientsAirway pressure
2020
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Liu S, Lin H, Baine I, Wajnberg A, Gumprecht J, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, Sanky C, Dupper A, Zheng A, Nguyen F, Amanat F, Stadlbauer D, Altman D, Chen B, Krammer F, Mendu D, Firpo-Betancourt A, Levin M, Bagiella E, Casadevall A, Cordon-Cardo C, Jhang J, Arinsburg S, Reich D, Aberg J, Bouvier N. Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study. Nature Medicine 2020, 26: 1708-1713. PMID: 32934372, DOI: 10.1038/s41591-020-1088-9.Peer-Reviewed Original ResearchConceptsPlasma recipientsSARS-CoV-2Convalescent plasmaLife-threatening COVID-19Suppress virus replicationConvalescent plasma therapyEffectiveness of convalescent plasma therapyScore-matched controlsVirus-specific antibodiesMount Sinai HospitalRandomized Controlled TrialsPlasma therapySevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Controlled studiesAcellular componentsControlled TrialsSyndrome coronavirus 2Sinai HospitalAntiviral effectPatientsOxygen requirementVirus replicationAntibodiesDevelopment and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation
Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, Schulz WL, Taylor RA. Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation. Annals Of Emergency Medicine 2020, 76: 442-453. PMID: 33012378, PMCID: PMC7373004, DOI: 10.1016/j.annemergmed.2020.07.022.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingEmergency Service, HospitalFemaleHumansMaleMiddle AgedOxygen Inhalation TherapyPandemicsPneumonia, ViralRespiratory InsufficiencyRetrospective StudiesRisk AssessmentSARS-CoV-2Severity of Illness IndexYoung AdultConceptsCOVID-19 Severity IndexQuick COVID-19 severity indexQuick Sequential Organ Failure AssessmentSequential Organ Failure AssessmentOrgan Failure AssessmentHours of admissionRespiratory failureSeverity IndexScoring systemSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Bedside scoring systemOxygen requirementPneumonia severity scoresHours of hospitalizationElixhauser Comorbidity IndexEmergency department patientsSeverity Index scoreCOVID-19 patientsSyndrome coronavirus 2Coronavirus disease 2019Failure AssessmentSimple scoring systemIndependent test cohort
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply